XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash Flows From Operating Activities:    
Net income (loss) $ 9,194,630 $ (32,535,982)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 69,942 94,392
Stock based compensation 754,361 1,359,000
Equity compensation expense 671
Non-cash interest expense 90,450
Change in fair value of derivative liabilities (12,417,450) 8,182,500
Issuance of common stock and warrants 20,590,717
Changes in operating assets and liabilities:    
Accounts receivable 1,164
Other receivable (115,000)
Prepaid expenses (302,034) (124,067)
Other current assets (607,376) (1,027,557)
Other non-current assets (819,626)
Accounts payable and accrued expenses 867,249 2,353,747
Income taxes payable (6,369)
Excise taxes 13,648
Net Cash Used In Operating Activities (2,342,278) (2,040,712)
Cash Flows From Investing Activities:    
Capitalized patent costs (40,156) (91,348)
Net Cash Used In Investing Activities (40,156) (91,348)
Cash Flows From Financing Activities:    
Capital contributions from Global Graphene Group 487,273
Cash received from NUBI Trust 25,160,047
Discount payment related to Non Redemption Agreement (13,937,997)
Reimbursement of consideration shares related to the Forward Purchase Agreement (2,193,800)
Reimbursement of Recycled Shares related to Forward Purchase Agreement (80,241)
Transaction expenses in connection with the Merger (8,948,009)
Inflow from Merger 17,555
Proceeds from convertible notes 527,500
Repayment of short-term notes (42,671) (424,277)
Proceeds from issuance of common stock and warrants in connection with the Private Placement 3,850,000
Proceeds from issuance of common stock from exercise of warrants 241,546
Issuance costs in connection with the Private Placement (262,064)
Repayment of related party payable (241,106)
Net Cash Provided By Financing Activities 198,875 3,954,881
Net change in cash (2,183,559) 1,822,821
Cash at beginning of period 3,353,732 780
Cash at end of period 1,170,173 1,823,601
Supplemental disclosure    
Cash paid for interest expense 7,329 77,795
Cash paid for federal income taxes 6,369
Supplemental disclosure of non-cash financing activities:    
Issuance of Common Stock upon the closing of the Merger 414 1,196
Convertible notes converted to common shares 527,500
Capitalized interest to principal balance of short-term note payable 90,450
Reverse stock split — reclassification from common stock to additional paid-in capital $ 13,311